Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-030417
Filing Date
2018-12-07
Accepted
2018-12-07 17:34:08
Documents
2
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14855
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4289
  Complete submission text file 0000899243-18-030417.txt   20594
Mailing Address C/O SERES HEALTH, INC. 161 FIRST STREET CAMBRIDGE MA 02472
Business Address
Kim Lorence H. (Reporting) CIK: 0001643746 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38753 | Film No.: 181224396

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)